Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDL23
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $152,135
Award facts
- Contract value 100% obligated
- $152,135.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 20, 2025, for Entyvio 300 mg vials with a firm fixed-price ceiling value of $152,135.28 and an ultimate completion date of September 11, 2025. This delivery order was issued without a set-aside designation and represents a direct supply of pharmaceutical products to support Department of Defense healthcare facilities. The contract is performed at the awardee's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The parent IDC, awarded under the SPE2DB program, enables the DLA to procure a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. Entyvio, a biologic immunosuppressant medication used primarily for inflammatory bowel disease, represents one of the specialized pharmaceutical products available for procurement through this vehicle, demonstrating DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain serving military healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FDL23?
SPE2DB25FDL23 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FDL23 worth?
The government has obligated $152,135 on SPE2DB25FDL23.
Is contract SPE2DB25FDL23 an order under another contract?
Yes. SPE2DB25FDL23 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL23 competed?
The extent of competition for SPE2DB25FDL23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award